跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,373 条关于
“IL-31 receptor”
全部
16,373
临床试验
6,999
药物
2,008
机构
139
资讯
7,227
2年前
FDA Approves Galderma's Nemluvio as First IL-31 Inhibitor for Prurigo Nodularis
去年
Nemolizumab Shows Sustained Efficacy in Long-Term Atopic Dermatitis Treatment
9个月前
Galderma Initiates Phase II Trial of Nemolizumab for Chronic Pruritus of Unknown Origin
去年
Advancements in Atopic Dermatitis and Prurigo Nodularis Therapies Highlighted at Fall Clinical 2024
去年
Galderma's Nemolizumab (Nemluvio) Receives FDA Approval for Moderate-to-Severe Atopic Dermatitis
2个月前
Attovia Therapeutics Raises $289M in Upsized IPO to Advance Biparatopic Nanobody Pipeline in Immunology
11天前
Chugai's Nemolizumab Research Honored with 11th JBDA Award for Drug Discovery
去年
Galderma Launches Phase II Trials of Nemolizumab for Systemic Sclerosis and Chronic Pruritus of Unknown Origin
去年
Galderma's Phase III OLYMPIA 1 Trial Results Show Nemolizumab Significantly Improves Prurigo Nodularis Symptoms
去年
Nemluvio Shows Sustained Long-Term Efficacy in Atopic Dermatitis with Two-Year Extension Data
第 1 页,共 723 页
上一页
下一页